Literature DB >> 16546607

Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid-sparing agent.

Mark M Tran, Grant J Anhalt, Terry Barrett, Bernard A Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16546607     DOI： 10.1016/j.jaad.2005.07.009

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

1.  The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room.

Authors:  Hyunhee Park
Journal:  J Clin Aesthet Dermatol       Date:  2011-01

Review 2.  Bullous Diseases in Children: A Review of Clinical Features and Treatment Options.

Authors:  Brittney Schultz; Kristen Hook
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

3.  Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up.

Authors:  Naveed Sami
Journal:  JAAD Case Rep       Date:  2015-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.